Submission to the Value Analysis Committee is a risk management requirement that must be completed prior to the purchase and use of any new or replacement technologies/devices ("Products") at UCLA. However, submission to the Value Analysis Committee is required if the Medical Center must purchase a product that is new to the Medical Center (i.e., not previously approved by the Committee and not already on the formulary).
[NOTE: If the intended use of an FDA-approved product is experimental or investigational, regardless of whether the product is FDA-approved under a 510K, PMA, HDE, or IDE, AND the Medical Center will not be required to purchase the product, then submission to the Value Analysis Committee is NOT REQUIRED. However, all experimental or investigational-use products DO REQUIRE a separate submission to the UCLA Medical Center Financial Services - Reimbursement Department for approval of any proposed or potential Standard of Care charges to insurance (please complete the separate UCLA version of the Palmetto-GBA IDE Request Form. You must also complete submissions for the IRB, financial disclosure per UC & CIRC policies, and the appropriate Contracts Office for execution of a clinical device trial/research agreement.]
[If there are multiple presenters for the product, it is recommended that the group coordinate their presentation prior to the meeting.]
The presentation will be followed by questions from the Committee members. (Questions to anticipate include efforts to standardize products and whether or not other departments will be impacted by the introduction of your new product).
The Committee is dedicated to directing our limited resources to the selection of products that have the greatest impact on patient care. Since the inception of the Value Analysis Committee, there have been many presentations that did not meet the Committee's requirements and resulted in products being denied. In these cases, the Committee felt the evidence did not support a high priority score.
Within approximately one week after the Committee meeting, a formal Value Analysis Committee Decision Memo will be sent to the requestor.
If you have any questions about the Value Analysis process, please contact Eimee Miura at (310) 794-0144 or by e-mail, EMiura@mednet.ucla.edu.
If you have any technical issues with the website or submission form, please contact Victor Banh by email at VBanh@mednet.ucla.edu.
To view the complete Value Analysis Request Flowchart, please click here.
Once ready to begin your Value Analysis Committee: Request for Purchase/Use of a New/Replacement Technology/Device submission, please click on the button below:
IMPORTANT: Note that there is no save feature in the Value Analysis Request Portal. Prior to beginning your form submission, please make sure you have all the necessary information and documentation. Requestors must also reattach their files to the form, if an error occurred during original submission. You must be connected to the UCLA network (intranet) to access the Value Analysis Request forms.
Thank you,
| Rick Edward Harrison, MD | William Quinones-Baldrich, MD | Philip Richard Levin, MD | ||
| Co-Chair | Co-Chair | Co-Chair | ||
| Value Analysis Committee | Value Analysis Committee | Value Analysis Committee |
